Ciprocopan Receives Marketing Approval in China for the Treatment of Patients with PNH Previously Untreated with Complement Inhibitors Life Science Investing
Beam Therapeutics to Present Updated Data from Phase 1/2 Trial of BEAM-302 in Alpha-1 Antitrypsin Deficiency in Late-Breaking Oral Presentation at the European Respiratory Society Congress 2026 Life Science Investing
Cyllene Therapeutics Expands Leadership Team to Support Corporate Growth and Clinical Product Development Life Science Investing
argenx Reports Half Year 2026 Financial Results and Provides Second Quarter Business Update Biotech Investing
Exelixis to Release Second Quarter 2026 Financial Results on Wednesday, August 5, 2026 Life Science Investing
Arcus Biosciences and Summit Therapeutics Enter Into Clinical Trial Collaboration to Evaluate Casdatifan Combined with Ivonescimab in Kidney Cancer Life Science Investing
Maravai LifeSciences To Host Earnings Conference Call on Thursday, August 6, 2026 Life Science Investing
Coherus Oncology to Report Second Quarter 2026 Financial Results on August 5, 2026 Life Science Investing
OKYO Pharma Announces Purchase of Shares by Chief Development Officer and Director Life Science Investing
